Related Experiment Video
Updated: May 6, 2026

11:22
Cardiac Muscle-cell Based Actuator and Self-stabilizing Biorobot - PART 1
Published on: July 11, 2017
8.2K
Biohybrid Microrobots Based on Jellyfish Stinging Capsules and Janus Particles for In Vitro Deep-Tissue Drug
Sinwook Park1,2, Noga Barak3, Tamar Lotan3
1School of Mechanical Engineering Tel-Aviv University Tel Aviv 6997801 Israel.
Small Science
|June 18, 2025
Summary
This study introduces novel biohybrid microrobots using jellyfish capsules for efficient deep-tissue drug delivery. These microrobots demonstrate precise navigation and targeted payload release for potential therapeutic applications.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Robotics
Background:
- Microrobots are crucial for micro/nanoscale manipulation and targeted drug delivery.
- Deep-tissue penetration and effective drug delivery remain significant challenges in current microrobot technology.
Purpose of the Study:
- To develop a novel biohybrid microrobot capable of deep-tissue penetration and targeted drug delivery.
- To utilize jellyfish-stinging capsules as natural nanoinjectors for enhanced delivery efficiency.
Main Methods:
- Assembled jellyfish-stinging capsules onto active Janus particles (JPs) to create biohybrid microrobots.
- Controlled microrobot transport and navigation using magnetic fields and capsule loading via electric fields.
- Activated capsule tubule ejection and payload release triggered by specific enzymes in vitro.
Main Results:
- Demonstrated successful penetration and drug/toxin delivery to cancer spheroids and live Caenorhabditis elegans in vitro.
- Validated the enzyme-triggered release mechanism for targeted payload delivery.
- Showcased the potential of biohybrid microrobots for precise navigation and delivery.
Conclusions:
- The developed biohybrid microrobots offer a promising approach for deep-tissue drug delivery.
- Future work may involve encapsulating diverse drugs and exploring in vivo applications.
- This technology could significantly advance targeted therapeutic strategies.
Related Concept Videos
Modified-Release Drug Delivery Systems: Stimuli-Activated
186
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
186
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
167
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
167

